Exvastat

"The founders, Drs. David Cavalla and Andrew McElroy, bring extensive experience in drug repurposing and a proven track record of success in pharmaceutical product development. The company is working to identify and advance imatinib for the treatment of serious and life-threatening conditions in patient populations with significant areas of unmet need, including ARDS."